NEW YORK, March 13, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of DaVita Inc. securities (NYSE:DVA) from August 5, 2015 through October 21, 2016, inclusive (the “Class Period”) of the important April 3, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for DaVita investors under the federal securities laws.
To join the DaVita class action, go to http://rosenlegal.com/cases-1026.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into unnecessary insurance plans in order to maximize profits; (2) DaVita was using American Kidney Fund as a vehicle to facilitate these improper practices; (3) as such, DaVita’s revenues and profits were illegally obtained; (4) in turn, DaVita lacked effective internal controls over financial reporting; and (5) as a result, Defendants’ statements about DaVita’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 3, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1026.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
John Ternus Signals Apple’s Future with Product-First AI Strategy
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 



